Amicus Brief Addresses PTAB Review of Obviousness-Type Double Patenting and Patent Term Issues Affecting Biotech ...
StockStory.org on MSN
A look back at biotechnology stocks’ Q4 earnings: Incyte (NASDAQ:INCY) vs. the rest of the pack
Looking back on biotechnology stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Incyte ...
Add Yahoo as a preferred source to see more of our stories on Google. Lululemon launched its first product using plant-based nylon in April 2023 Biotechnology is the exploitation of biological ...
Insilico Medicine ("Insilico", 3696.HK), a clinical-stage generative artificial intelligence (AI)-driven biotechnology ...
PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
The average one-year price target for Nautilus Biotechnology (NasdaqCM:NAUT) has been revised to $4.08 / share. This is an ...
Shares Biotechnology ETF (IBB) gives investors biotech exposure through large, established drug developers rather than ...
Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...
Curative Biotechnology, Inc. (OTC: CUBTD) ("Curative” or the "Company”), a development-stage biomedical company focused on novel treatments for degenerative eye diseases, today announced a reverse ...
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer – Updated Phase 1 ...
Explore the Scaling Biotechnology and Novel Foods report to discover how industry leaders overcome regulatory, manufacturing ...
In the rapidly evolving field of industrial biotechnology, bacteria have emerged as crucial agents driving innovation and sustainable development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results